Summary Information:
REGENXBIO Inc. Common Stock
NASDAQ:RGNX
email
admin@troach.net 		Our Main Pages
Stocks.TRoach.Net
TRoach.Org
TRoach.Net
NOTE: This page is for evaluation of a JFF Project.
This page is NOT updated on a regular basis.
Information on this page should NOT be used for investment purposes.
REGENXBIO Inc. Common Stock
Exchange: NASDAQ
Symbol: RGNX
SEC CIK: 0001590877
Phone: 240-552-8181
9804 MEDICAL CENTER DRIVE
ROCKVILLE MD 20850

CEO: Kenneth Mills
Price Quote by TradingView
Price when page updated: 19.22 Date: 2023-12-01
Company Website:
www.regenxbio.com

_Description: REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. REGENXBIO's NAV Technology Platform, a proprietary adeno-associated virus (AAV) gene delivery platform, consists of exclusive rights to more than 100 novel AAV vectors, including AAV7, AAV8, AAV9 and AAVrh10. REGENXBIO and its third-party NAV Technology Platform Licensees are applying the NAV Technology Platform in the development of a broad pipeline of candidates in multiple therapeutic areas.

IPO YEAR:
2015
 Sector:
Health Care
 Industry:
Biotechnology: Biological Products (No Diagnostic Substances)
ADRTSO:

MarketCap:
845525856.00
 Beta:
1.06620229661031
52 Week High:
50.26
 52 Week Low:
27.02
 52 Week Change:
-0.2962421711899791
Short Interest:

Short Date:

Shares Outstanding:
42769208
Dividend Rate:
0
 Dividend Yield:
N/A
ExDividend Date:

Latest EPS:

Latest EPS Date:
2 Nov 2022
Float:
0
return on Equity:
14.30%
 Consensus EPS:

Number Of Estimates:
EPS Surprise Dollar:

Eps Surprise Percent:

EBITDA:
$132.856M
ttmEPS:
-5.22
 Revenue:
$484.295M
 Gross Profit:
Cash:

Debt:

Institution Percent:
91.60%
Revenue Percent:

Revenue Per Employee:

Insider Percent:
0.40%
Return on Assets:
9.30%
 Return on Capital:

Profit Margin:
18.70%
Price to Sales:
2.10
 Price To Book:
1.59
 Short Ratio:
8.50
PE Ratio:
-6.787133288517305
 Employees:
306
 1Y Guesstimate
41.909:1.0:6


__The following are links to various summary and news pages for
__REGENXBIO Inc. Common Stock [ RGNX ].

__Note: Some Links might not have information for the company.


finance.Yahoo.com money.CNN.com NASDAQ research
WalletInvestor.com WSJ.com MarketBeat.com
finviz.com WallMine.com TheGlobeandMail.com
stock1010.com
NASDAQ - General Info SEC Insider Report Ownership Summary
Dividend History insiderbuyingselling.com
Facebook search Twitter search LinkedIn search
PRnewsWire.Com Google Forecast
tdameritrade.com BarChart.com
SeekingAlpha.com Markets.FT.com stocktwits.com
FinTel.io Ldmicro.com bloomberg.com
MarketWatch.com Reuters.com businessinsider.com
fool.com barrons.com zacks.com
GuruFocus.com Investing.com tipranks.com
thestreet.com nytimes.com earningswhispers.com
marketchameleon.com sunshineavenue.com stockinvest.us
stockanalysis.com stockconsultant.com ycharts.com
financialcontent.com docoh.com foxbusiness.com
cnbc.com investorsobserver.com tradingview.com
investopedia.com tmxmoney.com invest.cnyes.com
ask.com bing.com brave.com
duckduckgo.com ecosia.org excite.com
exalead.com gibiru.com hotbot.com
www.info.com infospace.com lycos.com
lukol.com metacrawler.com mojeek.com
becovi.com searx.thegpm.org search.com
swisscows.com webcrawler.com yahoo.com
yandex.com yep.com you.com




INDEX



Page design by: TRoach
Page Last Updated: 2023-12-01